Hints and tips:
...Pfizer was monitoring outbreaks of monkeypox “very closely”, he said....
...Speaking to banking editor Stephen Morris at the FT’s global banking summit last week, Anil also said that financial crime was an “industry challenge”....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...expects global demand for Covid vaccines to remain strong as new strains of coronavirus continue to emerge, giving it an opportunity to break into a market that has been dominated by frontrunners such as Pfizer...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...AT&T, cigarette maker Philip Morris International and drugmaker Pfizer have also managed to lower their borrowing costs with recent debt issuance....
...Using a “Reverse Morris Trust” structure, which combines a spin-off with a merger, the deal is expected to be tax-free for Pfizer shareholders but taxable to those in Mylan....
...Pfizer Japan and Himawari Life Insurance are among more than 20 companies doing so from next year....
...Morris Pearl, a former managing director for BlackRock and the head of the board of the Patriotic Millionaires, a group of high net worth individuals who’ve argued against tax cuts for the wealthy, says...
...Freemium v paid: Streaming competition swells YouTube is one of several Spotify competitors bringing streaming services to the market this year....
...The influence of Crosby Textor’s clients, who have in the past included Philip Morris, the tobacco company, has previously come under scrutiny when questions were raised about whether Mr Crosby had encouraged...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...and Philip Morris....
...Companies meeting the criteria, and yielding more than 4 per cent, include: Pfizer and Philip Morris in the US; and BAE Systems, AstraZeneca, Wolters Kluwer, Total, Renault, Royal Dutch Shell, Philips, Siemens...
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
..., Philip Morris, Merck....
...The US food group itself was created in a separation from parent Phillip Morris, which after a 2001 initial public offering sold the remainder of its stake six years later....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...“Our competitors get into these brand wars like Coke v Pepsi,” says Zimmer at UTA....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Other coroporate giants such as Coca-Cola and Philip Morris also performed well, rising 3.9 per cent to $44.40 and 3.2 per cent to $41.84 respectively....
...Philip Morris says federal law pre-empts the suit, which was brought under state consumer protection law....
International Edition